SOMATOSTATIN EUMEDICA
3MG INF PSO LQF 1+1ML
| SÚKL code | 0200725 |
|---|---|
| Name of the product | SOMATOSTATIN EUMEDICA 3 MG |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | SOMATOSTATIN EUMEDICA |
| Supplement | 3MG INF PSO LQF 1+1ML |
| Strenght | 3MG |
| Pharmaceutical form | Powder and solvent for solution for infusion |
| Package | 1+1ML |
| Route | Intravenous use |
| Wrap type | Ampoule |
| Legal status | na lékařský předpis |
| Active substance | SOMATOSTATIN (SOMATOSTATINUM) |
| ATC group | H01CB01 |
| ATC group name | SOMATOSTATIN |
Marketing authorisation information
| Registration Number | 56/ 224/93-B/C |
|---|---|
| Type of MA | National |
| MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
| Placed on the market till | 31. 07. 2019 |
| MA Holder | Eumedica SA, Brusel |
| MA Holder country | BELGIE |
| Actual MA holder | EUMEDICA Pharmaceuticals GmbH, Lörrach |
| Actual MA holder country | NĚMECKO |
cz